Columbia Research Enhanced Value ETF
REVS
2 hedge funds and large institutions have $5.27M invested in Columbia Research Enhanced Value ETF in 2019 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.
100% more funds holding
Funds holding: 1 → 2 (+1)
6% more capital invested
Capital invested by funds: $4.97M → $5.27M (+$302K)
0.58% less ownership
Funds ownership: 99.88% → 99.3% (-0.58%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$214K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$244K |
REVS Hedge Fund Activity: Q4 2019 in Review
2 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Columbia Research Enhanced Value ETF (REVS) for Q4 2019, worth a combined $5.27M — up 6.1% from $4.97M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new REVS positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Jane Street, opening a new position worth an estimated $214K. The largest seller was Wells Fargo, cutting an estimated $244K.
- 2 institutional investors held Columbia Research Enhanced Value ETF (REVS) as of Q4 2019, up from 1 in Q3 2019.
- Funds reported $5.27M of Columbia Research Enhanced Value ETF stock for Q4 2019, up 6.1% quarter-over-quarter.
- 1 fund opened new Columbia Research Enhanced Value ETF positions in Q4 2019 and 0 closed out, a net change of +1 holder.
- The largest Columbia Research Enhanced Value ETF buyer in Q4 2019 was Jane Street, an estimated $214K added.
- The largest Columbia Research Enhanced Value ETF seller in Q4 2019 was Wells Fargo, an estimated $244K sold.
Based on aggregated 13F filings for Q4 2019.